Allelic imbalance at the HER2/TOP2A locus in breast cancer

BACKGROUND: Breast cancer is a heterogeneous disease with various histological features and molecular markers. These are utilized for the prediction of clinical outcome and therapeutic decision making. In addition to well established markers such as HER2 overexpression and estrogen and progesterone...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diagn Pathol
Egile Nagusiak: Huijsmans, Cornelis J. J., van den Brule, Adriaan J. C., Rigter, Henny, Poodt, Jeroen, van der Linden, Johannes C., Savelkoul, Paul H. M., Hilbink, Mirrian, Hermans, Mirjam H. A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Methodology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4448206/
https://ncbi.nlm.nih.gov/pubmed/26022247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-015-0289-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak